デフォルト表紙
市場調査レポート
商品コード
1370391

自己免疫疾患診断市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Autoimmune Disease Diagnosis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 145 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.49円
自己免疫疾患診断市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年10月15日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

市場概要:

世界の自己免疫疾患診断市場規模は2022年に37億米ドルに達しました。今後、IMARC Groupは、同市場が2023年から2028年の間に5.8%の成長率(CAGR)を示し、2028年までに53億米ドルに達すると予測しています。自己免疫疾患の罹患率の増加、保険契約の売上高増加、EMRの利用拡大などが市場を牽引する主な要因です。

自己免疫疾患は、免疫系が身体の細胞、組織、臓器を攻撃する疾患群です。全身性エリテマトーデス(SLE)、多発性硬化症、関節リウマチ、i型糖尿病など、さまざまな病状によって引き起こされます。倦怠感、関節痛やこわばり、皮疹、発熱、消化不良などを伴う。また、臓器や組織に損傷を与え、呼吸困難、臓器不全、あるいは死亡などの重篤な症状を引き起こすこともあります。詳細な病歴の聴取、身体診察、特異的抗体を検出するための血液検査、損傷や炎症を探すための画像検査、罹患した組織を顕微鏡で調べるための生検など、様々なアプローチを組み合わせて診断することができます。

自己免疫疾患診断市場の動向:

自己免疫疾患の罹患者数の急増と、そのような病状を発症しやすい高齢化人口の増加は、世界中で自己免疫疾患診断の需要を促進する主な要因の一つです。さらに、自己免疫疾患、その症状、診断、治療オプションの容易な利用可能性に関する意識の高まりが、市場の成長を後押ししています。さらに、自己免疫疾患の診断や治療に対する経済的支援を提供し、医療費全体を削減する健康保険の導入が拡大していることも、市場にプラスの影響を与えています。これとは別に、自己免疫疾患を研究し新しい治療法を開発するための研究開発(R&D)プロジェクトに資金を提供している国もあります。また、自己免疫疾患の診断方法の改善を目的としたプログラムにも投資しています。そのほかにも、誰もが利用しやすい質の高いヘルスケア施設を提供するための取り組みも行っています。このことは、診断技術の著しい向上と相まって、市場の成長を強化しています。さらに、医療従事者がより包括的な患者情報にアクセスできるようになり、自己免疫疾患診断の正確性と迅速性を向上させるために電子カルテ(EMR)の使用が増加しています。このことは、遠隔医療の採用の増加とともに、遠隔自己免疫疾患診断・モニタリング技術の需要を喚起しています。これに加えて、従来の診断手順と比較して苦痛の少ない非侵襲的診断に対する需要の高まりが、市場に明るい展望をもたらしています。

本レポートで扱う主な質問

  • 世界の自己免疫疾患診断市場の規模は?
  • COVID-19が世界の自己免疫疾患診断市場に与えた影響は?
  • 世界の自己免疫疾患診断市場の期待成長率は?
  • 自己免疫疾患診断の世界市場を牽引する主要因は?
  • 自己免疫疾患診断の世界市場の製品タイプ別区分は?
  • 疾患タイプに基づく自己免疫疾患診断の世界市場内訳は?
  • 検査タイプに基づく自己免疫疾患診断の世界市場内訳は?
  • 自己免疫疾患診断の世界市場における主要地域は?
  • 世界の自己免疫疾患診断市場における主要プレイヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 自己免疫疾患診断の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品タイプ別

  • 消耗品とアッセイキット
    • 市場動向
    • 市場予測
  • 機器
    • 市場動向
    • 市場予測

第7章 市場内訳:疾患タイプ別

  • 全身性自己免疫疾患
    • 市場動向
    • 市場内訳:タイプ別
      • 関節リウマチ
      • 乾癬
      • 全身性エリテマトーデス(SLE)
      • 多発性硬化症
      • その他
    • 市場予測
  • 局所性自己免疫疾患
    • 市場動向
    • 市場内訳:タイプ別
      • 炎症性腸疾患
      • 1型糖尿病
      • 甲状腺
      • その他
    • 市場予測

第8章 市場内訳:検査タイプ別

  • ルーチン検体検査
    • 市場動向
    • 市場予測
  • 炎症マーカー
    • 市場動向
    • 市場予測
  • 自己抗体と免疫学的検査
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳:エンドユーザー別

  • 臨床検査
    • 市場動向
    • 市場予測
  • 病院
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • AESKU.GROUP
    • Danaher Corp.
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • PerkinElmer Inc.
    • Hemagen Diagnostics, Inc.
    • Inova Diagnostics, Inc.
    • Myriad Genetics, Inc.
    • Quest Diagnostics Incorporated
    • Siemens Healthineers AG
    • SQI Diagnostics
    • Thermo Fisher Scientific Inc.
    • Trinity Biotech plc
図表

List of Figures

  • Figure 1: Global: Autoimmune Disease Diagnosis Market: Major Drivers and Challenges
  • Figure 2: Global: Autoimmune Disease Diagnosis Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Autoimmune Disease Diagnosis Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: Autoimmune Disease Diagnosis Market: Breakup by Disease Type (in %), 2022
  • Figure 5: Global: Autoimmune Disease Diagnosis Market: Breakup by Test Type (in %), 2022
  • Figure 6: Global: Autoimmune Disease Diagnosis Market: Breakup by End-User (in %), 2022
  • Figure 7: Global: Autoimmune Disease Diagnosis Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 9: Global: Autoimmune Disease Diagnosis (Consumables and Assay Kits) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Autoimmune Disease Diagnosis (Consumables and Assay Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Autoimmune Disease Diagnosis (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Autoimmune Disease Diagnosis (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Autoimmune Disease Diagnosis (Systemic Autoimmune Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Autoimmune Disease Diagnosis (Systemic Autoimmune Disease) Market: Breakup by Disease Type (in %), 2022
  • Figure 15: Global: Autoimmune Disease Diagnosis (Systemic Autoimmune Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Autoimmune Disease Diagnosis (Localized Autoimmune Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Autoimmune Disease Diagnosis (Localized Autoimmune Disease) Market: Breakup by Disease Type (in %), 2022
  • Figure 18: Global: Autoimmune Disease Diagnosis (Localized Autoimmune Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Autoimmune Disease Diagnosis (Routine Laboratory Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Autoimmune Disease Diagnosis (Routine Laboratory Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Autoimmune Disease Diagnosis (Inflammatory Markers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Autoimmune Disease Diagnosis (Inflammatory Markers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Autoimmune Disease Diagnosis (Autoantibodies and Immunologic Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Autoimmune Disease Diagnosis (Autoantibodies and Immunologic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Autoimmune Disease Diagnosis (Other Test Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Autoimmune Disease Diagnosis (Other Test Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Autoimmune Disease Diagnosis (Clinical Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Autoimmune Disease Diagnosis (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Autoimmune Disease Diagnosis (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Autoimmune Disease Diagnosis (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Autoimmune Disease Diagnosis (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Autoimmune Disease Diagnosis (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: North America: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: North America: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: United States: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: United States: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Canada: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Canada: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Asia Pacific: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Asia Pacific: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: China: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: China: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Japan: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Japan: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: India: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: India: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: South Korea: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: South Korea: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Australia: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Australia: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Indonesia: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Indonesia: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Others: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Others: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Europe: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Europe: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Germany: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Germany: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: France: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: France: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: United Kingdom: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: United Kingdom: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Italy: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Italy: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Spain: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Spain: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Russia: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Russia: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Others: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Others: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Latin America: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Latin America: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Brazil: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Brazil: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Mexico: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Mexico: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Middle East and Africa: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Middle East and Africa: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Global: Autoimmune Disease Diagnosis Industry: SWOT Analysis
  • Figure 82: Global: Autoimmune Disease Diagnosis Industry: Value Chain Analysis
  • Figure 83: Global: Autoimmune Disease Diagnosis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Autoimmune Disease Diagnosis Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
  • Table 4: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 5: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 6: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Autoimmune Disease Diagnosis Market Structure
  • Table 8: Global: Autoimmune Disease Diagnosis Market: Key Players
目次
Product Code: SR112023A2250

Abstract

Market Overview:

The global autoimmune disease diagnosis market size reached US$ 3.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028. The increasing incidences of autoimmune diseases, rising sales of insurance policies, and the growing use of EMRs represent some of the key factors driving the market.

An autoimmune disease is a group of disorders wherein the immune system attacks the cells, tissues, and organs of the body. It can be caused by different medical conditions, such as systemic lupus erythematosus (SLE), multiple sclerosis, rheumatoid arthritis, and type I diabetes. It is associated with fatigue, joint pain and stiffness, skin rashes, fever, and digestive problems. It can also cause damage to organs and tissues, which leads to more severe symptoms like difficulty breathing, organ failure, or even death. It can be diagnosed via a combination of various approaches, such as taking a detailed medical history, performing a physical examination, blood tests to detect specific antibodies, imaging tests to look for damage or inflammation, and a biopsy to examine the affected tissue under a microscope.

Autoimmune Disease Diagnosis Market Trends:

The surging incidences of autoimmune diseases among individuals and the increasing aging population that are susceptible to develop such medical conditions represent one of the major factors driving the demand for autoimmune disease diagnosis around the world. Moreover, the rising awareness about autoimmune disease, its symptoms, diagnosis, and the easy availability of the treatment options is favoring the growth of the market. In addition, the growing implementation of health insurance policies that offer financial assistance for autoimmune disease diagnosis or treatment and reduce overall medical expenses is influencing the market positively. Apart from this, governing authorities of several countries are financing research and development (R&D) projects to study autoimmune diseases and develop new treatments. They are also investing in programs that aim to develop improved diagnostic methods for these medical disorders. Besides this, they are undertaking initiatives to offer quality healthcare facilities that are accessible to all. This, coupled with significant improvements in the diagnostic technologies, is strengthening the growth of the market. Furthermore, there is an increase in the use of electronic medical records (EMRs) to improve the accuracy and speed of autoimmune disease diagnosis as healthcare professionals have access to more comprehensive patient information. This, along with the rising adoption of telemedicine is catalyzing the demand for remote autoimmune disease diagnosis and monitoring technologies. Besides this, the growing demand for non invasive diagnosis, which is less painful as compared to traditional diagnostic procedures, is creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global autoimmune disease diagnosis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, disease type, test type and end-user.

Product Type Insights:

Consumables and Assay Kits

Instruments

The report has provided a detailed breakup and analysis of the autoimmune disease diagnosis market based on the product type. This includes consumables and assay kits, and instruments. According to the report, consumables and assay kits represented the largest segment.

Disease Type Insights:

Systemic Autoimmune Disease

Rheumatoid Arthritis

Psoriasis

Systemic Lupus Erythematosus (SLE)

Multiple Sclerosis

Others

Localized Autoimmune Disease

Inflammatory Bowel Disease

Type 1 Diabetes

Thyroid

Others

A detailed breakup and analysis of the autoimmune disease diagnosis market based on the disease type has also been provided in the report. This includes systemic autoimmune disease (rheumatoid arthritis, psoriasis, systemic lupus erythematosus (SLE), multiple sclerosis, and others) and localized autoimmune disease (inflammatory bowel disease, type 1 diabetes, thyroid, and others). According to the report, localized autoimmune disease (inflammatory bowel disease, type 1 diabetes, thyroid, and others) accounted for the largest market share.

Test Type Insights:

Routine Laboratory Tests

Inflammatory Markers

Autoantibodies and Immunologic Tests

Others

The report has provided a detailed breakup and analysis of the autoimmune disease diagnosis market based on the test type. This includes routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and others. According to the report, routine laboratory tests represented the largest segment.

End-User Insights:

Clinical Laboratories

Hospitals

Others

A detailed breakup and analysis of the autoimmune disease diagnosis market based on the end-user has also been provided in the report. This includes clinical laboratories, hospitals, and others. According to the report, clinical laboratories accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for autoimmune disease diagnosis. Some of the factors driving the North America autoimmune disease diagnosis market included the easy availability of treatments, technological advancements, extensive research and development (R&D) projects, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global autoimmune disease diagnosis market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, AESKU.GROUP, Danaher Corp., bioMerieux SA, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hemagen Diagnostics, Inc., Inova Diagnostics, Inc., Myriad Genetics, Inc., Quest Diagnostics Incorporated, Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech plc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What is the size of the global autoimmune disease diagnosis market?
  • 2. What has been the impact of COVID-19 on the global autoimmune disease diagnosis market?
  • 3. What is the expected growth rate of the global autoimmune disease diagnosis market?
  • 4. What are the key factors driving the global autoimmune disease diagnosis market?
  • 5. What is the breakup of the global autoimmune disease diagnosis market based on the product type?
  • 6. What is the breakup of the global autoimmune disease diagnosis market based on the disease type?
  • 7. What is the breakup of the global autoimmune disease diagnosis market based on the test type?
  • 8. What are the key regions in the global autoimmune disease diagnosis market?
  • 9. Who are the key players/companies in the global autoimmune disease diagnosis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Autoimmune Disease Diagnosis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Consumables and Assay Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Disease Type

  • 7.1 Systemic Autoimmune Disease
    • 7.1.1 Market Trends
    • 7.1.2 Market Breakup by Type
      • 7.1.2.1 Rheumatoid Arthritis
      • 7.1.2.2 Psoriasis
      • 7.1.2.3 Systemic Lupus Erythematosus (SLE)
      • 7.1.2.4 Multiple Sclerosis
      • 7.1.2.5 Others
    • 7.1.3 Market Forecast
  • 7.2 Localized Autoimmune Disease
    • 7.2.1 Market Trends
    • 7.2.2 Market Breakup by Type
      • 7.2.2.1 Inflammatory Bowel Disease
      • 7.2.2.2 Type 1 Diabetes
      • 7.2.2.3 Thyroid
      • 7.2.2.4 Others
    • 7.2.3 Market Forecast

8 Market Breakup by Test Type

  • 8.1 Routine Laboratory Tests
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Inflammatory Markers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Autoantibodies and Immunologic Tests
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Clinical Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AESKU.GROUP
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Danaher Corp.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 bioMerieux SA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bio-Rad Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 PerkinElmer Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Hemagen Diagnostics, Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Inova Diagnostics, Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Myriad Genetics, Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Quest Diagnostics Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Siemens Healthineers AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 SQI Diagnostics
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
    • 14.3.13 Thermo Fisher Scientific Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis
    • 14.3.14 Trinity Biotech plc
      • 14.3.14.1 Company Overview
      • 14.3.14.2 Product Portfolio
      • 14.3.14.3 Financials
      • 14.3.14.4 SWOT Analysis